Synovus Financial Corp Takeda Pharmaceutical CO LTD Transaction History

Synovus Financial Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$17.1 - $19.19 $96,341 - $108,116	-5,634 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$14.59 - $19.5 $13,495 - $18,037	-925 Reduced 14.1%	5,634 $101,000
Q1 2020 Apr 24, 2020	SELL	$13.02 - $20.31 $55,673 - $86,845	-4,276 Reduced 39.46%	6,559 $99,000
Q4 2019 Feb 06, 2020	BUY	$16.88 - $20.83 $33 - $41	2 Added 0.02%	10,835 $213,000
Q3 2019 Nov 01, 2019	BUY	$16.15 - $17.99 $48 - $53	3 Added 0.03%	10,833 $187,000
Q2 2019 Aug 08, 2019	BUY	$16.58 - $20.49 $1,707 - $2,110	103 Added 0.96%	10,830 $192,000
Q1 2019 May 09, 2019	BUY	$16.7 - $21.52 $179,140 - $230,845	10,727 New	10,727 $219,000

338

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.5B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Synovus Financial Corp with notifications on news.